The antiviral drug «Kagocel» has again been recognized as No. 1 antiviral agent against influenza and ARVI for adults and children from 3 years of age. The drug wins in this category for the third year in a r
The BioPHARMAHOLDING company, a member of the Nearmedic Group, has launched new COLLOST brand products
The antiviral drug Kagocel continues to cooperate with OZON, one of the largest Russian online stores
The antiviral drug Kagocel once again provides sponsorship for the organization and holding of a competition in one of the most beautiful and spectacular sports: from March 22 through March 28, the ISU World Figure Skating Champio…
JoinTechCell LLC, a company of the Nearmedic Group, has recently received the second international patent for the ESVIEF kit for isolating the stromal-vascular fraction from adipose tissue
The antiviral drug Kagocel continues to support figure skating competitions, and, and will sponsor the final stage of the Russian Cup competitions. The competition will be held in Moscow from February 26 to March 2, 2021
The antiviral drug Kagocel will continue to support figure skating competitions, despite the cancellation of the ISU European Championships in 2021 due to the Covid-19 pandemic
Dear friends, partners, and colleagues, Allow us to congratulate you on the coming New Year from the bottom of our hearts
The results of two more studies on the Russian antiviral drug Kagocel have recently been published in the international clinical trial database ClinicalTrials.gov
On December 3, 2020, the ESVIEF stromal-vascular fraction isolation kit developed by JointechCell LLC (part of Nearmedic Group) received a registration certificate
On December 16, the antiviral drug Kagocel was for the seventh time proclaimed winner of the annual Russian Pharma Awards in the category «Antiviral agent No. 1 in Russia against influenza and ARVI for adults and childr…
On December 10, the Kagocel antiviral drug won the Belorussian Choice of the Year contest in the category «Imported Antiviral Drug for the Treatment of ARVI and Flu» for the third time. The drug had already been granted thi…
The commercial Family Law created by the marketing team of the antiviral brand Kagocel, won silver at the MedMen Healthcare Creative Awards
Results of two post-registration clinical trials of the antiviral drug Kagocel effectiveness were published in the international database of clinical trials ClinicalTrials.gov
The Nearmedic Pharma company has launched a cashback program for the popular antiviral drug Kagocel. The promotion program has been developed in collaboration with the Wavemaker advertising agency
On October 26, 2020, the Ministry of Health of the Russian Federation published the ninth version of the temporary guidelines Prevention, diagnosis, and treatment of the new coronavirus infection (COVID-19) on its official we…
In early October, the Nearmedic Group presented the latest test system SARS-COV-2-RBD-ELISA-GAMALEI designed for testing protective immunity to the SARS-CoV-2 virus at two authoritative conferences for the scientific and medical community
On October 1, a new creative advertising campaign developed by the marketing team of the antiviral brand Kagocel and Twiga creative agency will start on Russian TV and in digital media
On October 1, Nearmedic Plus started mass production of the latest test systems designed to test for protective immunity to the SARS-CoV-2 virus, developed by the National Research Center for Epidemiology and Microbiology nam…
Next year, it is planned to start production of a new line of Martiflex medical products for bone regeneration: Matriflex APATITE, Matriflex MATRIX, and Matriflex COLLAGEN. The production is to be launched at t…
On August 11-13, 2020, the Nearmedic group took part in the all—Russia forum Health of the Nation as the Basis of Russia’s Prosperity
On August 4, 2020, JoinTechCell LLC of the Nearmedic group of companies received its first international patent for the ESVIEF set designed to isolate the stromal-vascular fraction from adipose tissue for use in regenerative medic…
The Fundamental and Clinical Medicine journal published the results of a study on laboratory animals on the effectiveness of replacing bone defects using the Russian medical product Bongraf COLLAGEN. The product has the working name of…
The antiviral drug Kagocel will once again become the official sponsor of the ISU European Figure Skating Championships and ISU World Figure Skating Championships be held in 2021. The brand has been supporting those sports events since 2018
For the second year in a row, Kagocel was recognized by Smartpharma Awards 2020 as the best influenza and ARVI antiviral agent in Russia for adults and children from 3 years old. The award ceremony was held in a solemn a…
The 48th Central Research Institute of the Russian Federation Ministry of Defense (CRI 48) has studied the antiviral activity of the drug Kagocel in relation to a new pandemic strain of SARS-CoV-2 in the course of&n…
On May 28, 2020, two advertising campaigns of the Kagocel brand became winners of the XX Silver Mercury Festival of Creativity in Marketing Communications
The Nearmedic group of companies is preparing to produce the pharmaceutical substance of the new original anti-tuberculosis drug Makozinone. The drug was developed by Nearmedic group and the Swiss company École Polytechnique F&e…
On April 16, 2020, the innovative biotechnological company Sistema-Biotech (part of the Sistema Group of companies) received a registration certificate from the Federal Service for Healthcare Supervision (Roszdravnadzor) for a tes…
The Nearmedic group of companies delivered special personal protective equipment — transport isolation boxes and special clothing — during the COVID-19 pandemic to medical institutions in Russia